Shell Asset Management CO Corcept Therapeutics Inc Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Shell Asset Management CO holds 8,510 shares of CORT stock, worth $490,856. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,510

Previous 9,001 5.45%

Holding current value

$490,856

Previous $292,000 34.93%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$29.51 - $46.26 $14,489 - $22,713	-491 Reduced 5.45%	8,510 $394,000
Q1 2024 Jul 31, 2024	SELL	$21.1 - $27.46 $11,963 - $15,569	-567 Reduced 5.93%	9,001 $292,000
Q1 2024 May 14, 2024	SELL	$21.1 - $27.46 $7,258 - $9,446	-344 Reduced 3.47%	9,568 $241,000
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $73,566 - $97,456	-2,964 Reduced 23.02%	9,912 $322,000
Q3 2023 Nov 08, 2023	SELL	$21.97 - $33.8 $4,899 - $7,537	-223 Reduced 1.7%	12,876 $351,000
Q2 2023 Jul 28, 2023	SELL	$21.44 - $25.15 $101,689 - $119,286	-4,743 Reduced 26.58%	13,099 $291,000
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $1,190 - $1,517	-62 Reduced 0.35%	17,842 $386,000
Q4 2022 Feb 07, 2023	SELL	$19.95 - $29.96 $74,453 - $111,810	-3,732 Reduced 17.25%	17,904 $364,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $139,999 - $165,052	-5,668 Reduced 20.76%	21,636 $555,000
Q2 2022 Aug 09, 2022	BUY	$17.33 - $25.3 $831 - $1,214	48 Added 0.18%	27,304 $649,000
Q1 2022 May 04, 2022	SELL	$16.53 - $25.21 $66,632 - $101,621	-4,031 Reduced 12.88%	27,256 $614,000
Q4 2021 Feb 09, 2022	BUY	$17.1 - $23.34 $2,565 - $3,501	150 Added 0.48%	31,287 $619,000
Q3 2021 Nov 04, 2021	SELL	$19.68 - $22.53 $26,371 - $30,190	-1,340 Reduced 4.13%	31,137 $613,000
Q2 2021 Aug 12, 2021	BUY	$19.97 - $24.43 $161,876 - $198,029	8,106 Added 33.26%	32,477 $714,000
Q1 2021 May 10, 2021	SELL	$23.49 - $30.56 $3,288 - $4,278	-140 Reduced 0.57%	24,371 $580,000
Q2 2020 Aug 10, 2020	BUY	$11.0 - $18.26 $269,621 - $447,570	24,511 New	24,511 $412,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.18B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Corcept Therapeutics Inc Transaction History